Updated:
Zhongshan Venture Capital
Zhongshan Venture Capital manages government-linked investments in biotechnology and healthcare startups in China.
Zhongshan Venture Capital
Zhongshan Venture Capital was established in 2015 as the investment arm of Zhongshan Financial Investment Holdings. Its controlling shareholder is the Zhongshan Municipal Government SASAC. The firm executes policy-directed equity investments alongside its parent group. It allocates across early-stage seed and startup rounds as well as expansion opportunities. Confirmed holdings include Xincheng Semiconductor, Hengsai Biologicals, TenNor Therapeutics, and Leman Biotech. Additional positions cover Maileite and Boceda in industrial sectors. Activity centers on China with emphasis on Guangdong province. The firm reports no disclosed headcount or additional offices. It maintains membership in the Asset Management Association of China since 2016 and works with Ernst & Young for accounting services from 2022. In 2022 it participated in the Zhongshan Most Socially Responsible Enterprise Media Awards. Control rests with the municipal SASAC, creating a direct link between local government industrial policy and investment decisions. This structure channels capital through the Zhongshan High-quality Development Mother Fund and multiple sector-specific vehicles.
General information
Firm type
Generalist
Year founded
2015
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Zhongshan
Corporate office
Area B, 12/F, Block 6, Shangfeng Zima Pentium, No. 2, Zhongshan 5th Road, Zhongshan, Guangdong, China
Sector focus
Frequently asked questions
Who controls investment decisions at Zhongshan Venture Capital?
The Zhongshan Municipal Government SASAC serves as ultimate controlling shareholder. Decisions align with municipal industrial policy objectives.
Does Zhongshan Venture Capital commit to external funds or focus on direct holdings?
It executes direct holdings in startups and operates through the Zhongshan High-quality Development Mother Fund. Positions include Xincheng Semiconductor and TenNor Therapeutics.
Which stages does Zhongshan Venture Capital target?
The firm targets early-stage seed and startup rounds as well as expansion and growth opportunities. Strategies are recorded as Early Stage, Venture, and Fund of Funds.
What is the relationship between Zhongshan Venture Capital and Zhongshan Investment Holding Group?
Zhongshan Investment Holding Group acts as the direct parent company and core operational platform. The venture capital entity sits within this group structure.
Where does Zhongshan Venture Capital source its capital?
Capital originates from the Zhongshan Municipal Government SASAC. The firm also manages the Zhongshan High-quality Development Mother Fund with scale exceeding 15 billion RMB.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: